Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ciclosporin 0.1% / 1 mg/mL eye drops (Verkazia®)

Brand: Verkazia®
Indication: Severe vernal keratoconjunctivitis in children from 4 years of age and adolescents.
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: No


• Suitable for prescribing in primary care following recommendation or initiation by a specialist.
• Little or no specific monitoring required.
• Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
• Brief prescribing document or information sheet may be required.

Primary care prescribers must be familiar with the drug to take on prescribing responsibility or must get the required information.
When recommending or handing over care, specialists should ask primary care prescribers to take over prescribing responsibility, and should give enough information about the indication, dose, monitoring requirements, use outside product licence and any necessary dose adjustments to allow them to confidently prescribe.


LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Ciclosporin Verkazia New Medicine Recommendation (241.8 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG